Signatur:	148
Titel:	Sonderforschungsbereiche. SFB-Initiativen
Laufzeit:	o.D.
Enthält:	Enth. u.a.: - Projekt von Prof. Dr. Rainer Spang: "Statistical Models of Oncogenic Events in Tumor Progression"; - Projekt von Prof. Dr. Christoph Klein und Miodrag Guzvic: "A molecular clock for the somatic progression of human cancer cells"; - Projekt von PD Dr. Michael Rehli und PD Dr. Wolfgang Dietmaier: "Influence of genetic and epigenetic aberrations on metastatic progression in CRC"; - Projekt von Dr. Albert Dowejko und Dr. Richard Bauer: "Role of the putative tumor suppressor HECA in the systemic progression of the head and neck squamous cell carcinoma (HNSCC); - Projekt von Anja Bosserhoff: "CYLD - an early mediator of melanoma metastasis?"; - Projekt von Sven Lang: "Role of mTOR complex 2 (mTORC2) for liver and lymph node metastases of human gastrointestinal cancer"; - Projekt von PD Dr. Anne Rascle: "Genetic and epigenetic alterations during STAT5-induced cell transformation, tumorigenesis and metastasis"; - Projekt von Prof. Dr. Daniela Männel: "The formative influence of the immune system on emerging metastases during cancer develophment"; - Projekt von PD Dr. Gero Brockhoff und Dr. Anja Wege: "Elucidation of the immunological impact in antibody based therapy of breast cancer using humanized mice, in-vivo imaging and multiparametric single cell based analysis"; - Projekt von Dr. Alexander Krömer: "Innate Immunosurveillance of Metastatic Disease"; - Projekt von Prof. Dr. Pompiliu Piso, Dr. Elke Eggenhofer und Dr. Gabriel Glockzin: "Critical role for mesenchymal stem cells (MSC) and MSC-derived tumor-associated fibroblasts (TAF) for peritoneal dissemination of GI malignancies"; - Projekt von Claus Hellerbrand: "Analysis of mechanisms promoting hepatic steatosis and steatohepatitis as highly permissive niche for metastases"; - Projekt von Dr. Bernhard Polzer und Prof. Dr. Christoph Klein: "Identification and molecular characterization of DTC subpopulations in their bone marrow niche(s)"; - Projekt von PD Dr. Christian Josef: "Genetic analysis of circulating tumor cells in metastatic melanoma patients with chemotherapy"; - Projekt von PD Dr. Gero Brockhoff: "Identification of molecular (non-)response signatures for Trastuzumab therapy in systemic breast cancer by multiplexed cytogenetic immunophenotyping"; - Projekt von Marina Kreutz und Eva Gottfried: "Tumor metabolism and immune cell infiltration in primary colon carcinoma and liver metastases"; - Projekt von PD Dr. Christian Hafner: "Genetic analysis of clonal evolution and therapy induced clonal selection in metastatic melanoma - a longitudinal study"; - Projekt von Prof. Dr. Albrecht Reichle und PD Dr. Wolfgang Dietmaier: "Tumors are reconstructible evolutionary system: Reverse engineering of tumor-associated inflammatory processes in metastatic cancer"; - Projekt von PD Dr. Anne Rascle: "Genetic and epigenetic alterations during cell transformation and tumorigenesis iduced by a constitutively active form of STAT5"; - Projekt von PD Dr. Gero Brockhoff: "Multiplexed cytogenetic immunophenotyping to identify molecular response signatures for targeted therapies in systemic breast cancer"; - Projekt von PD Dr. Hau Peter und PD Dr. Martin Proescholdt: "A dissection of molecular and metabolomic mechanisms of early tumor metastasis to the brain"; - Projekt von Prof. Dr. Eugen Kerkhoff: "Function and evaluation of vesicle transport processes in tumor development and progression"; - Projekt von Dr. Thomas Hehlgans: "The Functional Role of Beta-Defensins in Tumor Angiogenesis and Metastasis"; - Projekt von Gunter Meister: "The role of microRNAs in metastasis"; - Projekt von Prof. Dr. Pompiliu Piso: "Epigenetic and microenvironmental changes promoting peritoneal tumor cell dissemination in gastrointestinal malignancies".
Bestellsignatur:	Rep. 158 (Lehrstuhl Prof. Dr. Hofstädter, Ferdinand), 148